Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 58

1.

Hepatitis C virus (HCV) and lymphomagenesis.

Weng WK, Levy S.

Leuk Lymphoma. 2003 Jul;44(7):1113-20. Review.

PMID:
12916862
2.

Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles.

Hsu M, Zhang J, Flint M, Logvinoff C, Cheng-Mayer C, Rice CM, McKeating JA.

Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):7271-6. Epub 2003 May 21.

3.

L-SIGN (CD 209L) is a liver-specific capture receptor for hepatitis C virus.

Gardner JP, Durso RJ, Arrigale RR, Donovan GP, Maddon PJ, Dragic T, Olson WC.

Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4498-503. Epub 2003 Apr 3.

4.

Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR.

Pöhlmann S, Zhang J, Baribaud F, Chen Z, Leslie GJ, Lin G, Granelli-Piperno A, Doms RW, Rice CM, McKeating JA.

J Virol. 2003 Apr;77(7):4070-80.

5.
6.

DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2.

Lozach PY, Lortat-Jacob H, de Lacroix de Lavalette A, Staropoli I, Foung S, Amara A, Houles C, Fieschi F, Schwartz O, Virelizier JL, Arenzana-Seisdedos F, Altmeyer R.

J Biol Chem. 2003 May 30;278(22):20358-66. Epub 2003 Feb 27.

7.

Characterization of secreted and intracellular forms of a truncated hepatitis C virus E2 protein expressed by a recombinant herpes simplex virus.

Lucas M, Tsitoura E, Montoya M, Laliotou B, Aslanoglou E, Kouvatsis V, Entwisle C, Miller J, Klenerman P, Hadziyannis A, Hadziyannis S, Borrow P, Mavromara P.

J Gen Virol. 2003 Mar;84(Pt 3):545-54.

PMID:
12604804
8.

Binding of the hepatitis C virus E2 glycoprotein to CD81 is strain specific and is modulated by a complex interplay between hypervariable regions 1 and 2.

Roccasecca R, Ansuini H, Vitelli A, Meola A, Scarselli E, Acali S, Pezzanera M, Ercole BB, McKeating J, Yagnik A, Lahm A, Tramontano A, Cortese R, Nicosia A.

J Virol. 2003 Feb;77(3):1856-67.

9.

Recognition of native hepatitis C virus E1E2 heterodimers by a human monoclonal antibody.

Cocquerel L, Quinn ER, Flint M, Hadlock KG, Foung SK, Levy S.

J Virol. 2003 Jan;77(2):1604-9.

10.
11.
12.

The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus.

Scarselli E, Ansuini H, Cerino R, Roccasecca RM, Acali S, Filocamo G, Traboni C, Nicosia A, Cortese R, Vitelli A.

EMBO J. 2002 Oct 1;21(19):5017-25.

13.

Intramembrane proteolysis promotes trafficking of hepatitis C virus core protein to lipid droplets.

McLauchlan J, Lemberg MK, Hope G, Martoglio B.

EMBO J. 2002 Aug 1;21(15):3980-8.

14.

Analysis of antigenicity and topology of E2 glycoprotein present on recombinant hepatitis C virus-like particles.

Clayton RF, Owsianka A, Aitken J, Graham S, Bhella D, Patel AH.

J Virol. 2002 Aug;76(15):7672-82. Erratum in: J Virol 2002 Sep;76(18):9562.

15.

Structural features of envelope proteins on hepatitis C virus-like particles as determined by anti-envelope monoclonal antibodies and CD81 binding.

Triyatni M, Vergalla J, Davis AR, Hadlock KG, Foung SK, Liang TJ.

Virology. 2002 Jun 20;298(1):124-32.

16.

Reconstitution of hepatitis C virus envelope glycoproteins into liposomes as a surrogate model to study virus attachment.

Lambot M, Frétier S, Op De Beeck A, Quatannens B, Lestavel S, Clavey V, Dubuisson J.

J Biol Chem. 2002 Jun 7;277(23):20625-30. Epub 2002 Apr 5.

17.
18.

Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein.

Crotta S, Stilla A, Wack A, D'Andrea A, Nuti S, D'Oro U, Mosca M, Filliponi F, Brunetto RM, Bonino F, Abrignani S, Valiante NM.

J Exp Med. 2002 Jan 7;195(1):35-41.

19.
20.

Biogenesis of hepatitis C virus envelope glycoproteins.

Op De Beeck A, Cocquerel L, Dubuisson J.

J Gen Virol. 2001 Nov;82(Pt 11):2589-95. Review. No abstract available.

PMID:
11602769

Supplemental Content

Support Center